Privia Health Group, Inc. (PRVA)
- Previous Close
24.90 - Open
24.91 - Bid 17.98 x 200
- Ask 32.00 x 200
- Day's Range
24.83 - 25.21 - 52 Week Range
15.92 - 26.09 - Volume
686,356 - Avg. Volume
864,675 - Market Cap (intraday)
3.05B - Beta (5Y Monthly) 0.87
- PE Ratio (TTM)
208.50 - EPS (TTM)
0.12 - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
30.10
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. The company also operates accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.
www.priviahealth.com1,140
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PRVA
View MorePerformance Overview: PRVA
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PRVA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PRVA
View MoreValuation Measures
Market Cap
3.04B
Enterprise Value
2.57B
Trailing P/E
207.50
Forward P/E
47.39
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.75
Price/Book (mrq)
4.60
Enterprise Value/Revenue
1.43
Enterprise Value/EBITDA
89.54
Financial Highlights
Profitability and Income Statement
Profit Margin
0.87%
Return on Assets (ttm)
1.21%
Return on Equity (ttm)
3.01%
Revenue (ttm)
1.8B
Net Income Avi to Common (ttm)
15.62M
Diluted EPS (ttm)
0.12
Balance Sheet and Cash Flow
Total Cash (mrq)
469.33M
Total Debt/Equity (mrq)
0.77%
Levered Free Cash Flow (ttm)
110.63M